Skip to main content
Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India flag India · Delayed Price · Currency is INR
1,590.20
+5.40 (0.34%)
Jun 6, 2025, 3:30 PM IST

Glenmark Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, Glenmark Pharmaceuticals had annual revenue of 134.35B INR with 6.25% growth. Glenmark Pharmaceuticals had revenue of 32.68B in the quarter ending March 31, 2025, a decrease of -16.11%.

Revenue
134.35B
Revenue Growth
+6.25%
P/S Ratio
3.34
Revenue / Employee
8.96M
Employees
14,989
Market Cap
448.76B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025134.35B7.90B6.25%
Mar 31, 2024126.45B9.90B8.49%
Mar 31, 2023116.56B-6.49B-5.28%
Mar 31, 2022123.05B13.61B12.44%
Mar 31, 2021109.44B2.87B2.69%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 525.78B
Divi's Laboratories 93.60B
Cipla 271.45B
Apollo Hospitals Enterprise 217.94B
Mankind Pharma 122.07B
Zydus Lifesciences 232.42B
Aurobindo Pharma 317.24B
Alkem Laboratories 129.65B
Revenue Rankings

Glenmark Pharmaceuticals News

More News